Company: HRTX
Filing Date: 2025-09-09
Form Type: S-3
Source: 0000950170-25-113830
Chunk: 34

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-09-09
Form: S-3
Chunk 34
---
”) of the Company since April 2023, and as a director since February 2023. The address of Velan Capital Master Fund, LP is 100 North Main Street, Suite 301, Alpharetta, Georgia, 30009. |
| (5) | The shares reported under “Number of Shares of Common Stock Owned Prior to Offering” consist of (i) 6,976,804 shares of Common Stock held by Clearline Capital Partners Master Fund LP and (iii) 2,270,650 shares of Common Stock issuable upon the conversion of the Series A Convertible Preferred Stock to Clearline Capital Partners Master Fund LP. Clearline Capital Partners LP and Clearline Capital Partners Master Fund LP are collectively referred to herein as the “Clearline Funds.” The Clearline Funds are managed or sub-managed by Clearline Capital LP, as applicable. The general partner of Clearline Capital LP is Clearline Capital GP LLC. The managing member of Clearline Capital GP LLC is Marc Majzner. Mr. Majzner may be deemed to have shared voting and investment power of the securities managed or sub-managed, as applicable, by Clearline Capital LP. Mr. Majzner disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. The address of the Clearline Funds is 950 3rd Ave, 23rd Floor, New York, NY 10022.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| (6) | The shares reported under “Number of Shares of Common Stock Owned Prior to Offering” consist of (i) 2,387,225 shares of Common Stock and (ii) 946,100 shares of Common Stock issuable upon the conversion of the Series A Convertible Preferred Stock to Adage Capital Partners, L.P. Bob Atchinson and Phillip Gross are the managing members of Adage Capital Advisors, L.L.C., which is the managing member of Adage Capital Partners GP, L.L.C., which is the general partner of Adage, and each such person or entity, as the case may be, has shared voting and/or investment power over the securities held by Adage and may be deemed the beneficial owner of such securities, and each such person or entity, as the case may be, disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. The address of these funds and persons is 200 Clarendon St., 52nd Floor, Boston, MA